Targeting MAGE-C1/CT7 Expression Increases Cell Sensitivity to the Proteasome Inhibitor Bortezomib in Multiple Myeloma Cell Lines

Files in this item

This item appears in the following Collection(s)

Search DSpace



Browse

My Account

Statistics